CANNTAB UPDATE Cann Global Limited (ASX:CGB) (“Company” or the “Company” had previously advised the market on 17 June that the shipment of two of the six Canntab products was imminent. The company is pleased to advise that the unique CBD 12.5mg and CBD 25mg pharmaceutical grade hard pill formulations have been received in Australia. Canntab’s CBD proprietary immediate release cannabidiol formulations will be available for ordering by pharmacies once the shipment has cleared customs. The products can be prescribed by practitioners via the Special Access Scheme Category B application pathway. The SAS is a mechanism by which individual patients can access an unapproved therapeutic good through their health practitioner. It allows certain health practitioners to access therapeutic goods that are not included in the Australian Register of Therapeutic Goods (ARTG) for a single patient. Cann Global continue to work closely with Canntab and will update the market when the remaining four products ordered have been received in the country. ABOUT CANNGLOBAL Cann Global Limited (ASX:CGB) is a driving force in the hemp food and medical Cannabis industries. Our strength comes fro
CGB Price at posting:
0.6¢ Sentiment: None Disclosure: Held
had previously advised the market on 17 June that the shipment of two of the six Canntab products was imminent. The company is pleased to advise that the unique CBD 12.5mg and CBD 25mg pharmaceutical grade hard pill formulations have been received in Australia. Canntab’s CBD proprietary immediate release cannabidiol formulations will be available for ordering by pharmacies once the shipment has cleared customs. The products can be prescribed by practitioners via the Special Access Scheme Category B application pathway. The SAS is a mechanism by which individual patients can access an unapproved therapeutic good through their health practitioner. It allows certain health practitioners to access therapeutic goods that are not included in the Australian Register of Therapeutic Goods (ARTG) for a single patient. Cann Global continue to work closely with Canntab and will update the market when the remaining four products ordered have been received in the country. ABOUT CANNGLOBAL Cann Global Limited (ASX:CGB) is a driving force in the hemp food and medical Cannabis industries. Our strength comes fro
